Table 2.
Evaluation of zinc serum level with different variables in the two groups.
| Variable | Group | Zinc serum level | p value | ||
|---|---|---|---|---|---|
| Microgram/deciliter | |||||
| Increased level | Normal | Deficiency | |||
| IHD | Control | 1 (50) | 1 (50) | - | 0.003 |
| Patient | 23 (76.7) | 7 (23.3) | - | ||
| Stroke | Ischemic | 68 (75.6%) | 19 (21%) | 3 (3.3%) | |
| Hemorrhagic | 4 (40%) | 6 (60%) | 0 (0%) | 0.025 | |
| HLP | Control | 17 (34) | 24 (48) | 9 (18) | 0.04 |
| Patient | 24 (68.6) | 11 (31.4) | - | ||
Data are odds ratio (99% CI). Models are adjusted for age, sex, diabetes, smoking, HLP, and zinc serum level. Data are odds ratio (99% CI). Models are adjusted for age, sex, Diabetes, smoking, HLP, and zinc serum level. IHD: ischemic heart disease and HLP: hyperlipidemia.